Patent · US Active

Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives

US11254668B2 · kind B2 · utility

0Cited by

1References

10Claims

0Family size

Assignee

PFIZER INC. · US

Inventors

Brian Stephen Gerstenberger · Brookline, US
Andrew Fensome · Wayne, US
Dafydd Rhys Owen · Concord, US
Matthew Frank Brown · Stonington, US
Matthew Merrill Hayward · Old Lyme, US
Felix Vajdos · Ledyard, US
Li Xing · Lexington, US
Stephen Wayne Wright · Old Lyme, US

Key dates

Filing date	Aug 9, 2018
Grant date	Feb 22, 2022
Priority date	—
Expiry date	Nov 22, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A compound having the structure: or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein variables are defined in the specification. Also provided are methods of treatment as Janus Kinase inhibitors and pharmaceutical compositions containing the compounds of the invention and combinations thereof with other therapeutic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.